These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7119301)
1. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. Toogood JH; Baskerville JC; Jennings B; Lefcoe NM; Johansson SA J Allergy Clin Immunol; 1982 Oct; 70(4):288-98. PubMed ID: 7119301 [TBL] [Abstract][Full Text] [Related]
2. Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids. Brown PH; Blundell G; Greening AP; Crompton GK Respir Med; 1991 Nov; 85(6):501-10. PubMed ID: 1775677 [TBL] [Abstract][Full Text] [Related]
3. Dosing regimen of budesonide and occurrence of oropharyngeal complications. Toogood JH; Jennings B; Baskerville J; Anderson J; Johansson SA Eur J Respir Dis; 1984 Jan; 65(1):35-44. PubMed ID: 6705856 [TBL] [Abstract][Full Text] [Related]
4. Four-times-a-day dosing frequency is better than a twice-a-day regimen in subjects requiring a high-dose inhaled steroid, budesonide, to control moderate to severe asthma. Malo JL; Cartier A; Merland N; Ghezzo H; Burek A; Morris J; Jennings BH Am Rev Respir Dis; 1989 Sep; 140(3):624-8. PubMed ID: 2551204 [TBL] [Abstract][Full Text] [Related]
5. Large volume spacer devices and the influence of high dose beclomethasone dipropionate on hypothalamo-pituitary-adrenal axis function. Brown PH; Greening AP; Crompton GK Thorax; 1993 Mar; 48(3):233-8. PubMed ID: 8497821 [TBL] [Abstract][Full Text] [Related]
6. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. Hanania NA; Chapman KR; Sturtridge WC; Szalai JP; Kesten S J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):571-9. PubMed ID: 7499672 [TBL] [Abstract][Full Text] [Related]
7. Personal observations on the use of inhaled corticosteroid drugs for chronic asthma. Toogood JH; Jennings B; Baskerville J; Lefcoe NM Eur J Respir Dis; 1984 Jul; 65(5):321-38. PubMed ID: 6378649 [TBL] [Abstract][Full Text] [Related]
8. Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects. Brown PH; Matusiewicz SP; Shearing C; Tibi L; Greening AP; Crompton GK Thorax; 1993 Oct; 48(10):967-73. PubMed ID: 8256242 [TBL] [Abstract][Full Text] [Related]
9. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Toogood JH; Baskerville J; Jennings B; Lefcoe NM; Johansson SA Am Rev Respir Dis; 1984 May; 129(5):723-9. PubMed ID: 6721271 [TBL] [Abstract][Full Text] [Related]
10. Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. Toogood JH; Baskerville J; Jennings B; Lefcoe NM; Johansson SA J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):688-700. PubMed ID: 2681331 [TBL] [Abstract][Full Text] [Related]
11. Twice daily inhalation of a new corticosteroid, budesonide, in the treatment of chronic asthma. Willey RF; Godden DJ; Carmichael J; Preston P; Frame MH; Crompton GK Eur J Respir Dis Suppl; 1982; 122():138-42. PubMed ID: 6958478 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler. Toogood JH; White FA; Baskerville JC; Fraher LJ; Jennings B J Allergy Clin Immunol; 1997 Feb; 99(2):186-93. PubMed ID: 9042043 [TBL] [Abstract][Full Text] [Related]
13. Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma. Ebden P; Jenkins A; Houston G; Davies BH Thorax; 1986 Nov; 41(11):869-74. PubMed ID: 3547757 [TBL] [Abstract][Full Text] [Related]
14. High dose nebulized steroid in the treatment of chronic steroid-dependent asthma. Otulana BA; Varma N; Bullock A; Higenbottam T Respir Med; 1992 Mar; 86(2):105-8. PubMed ID: 1615174 [TBL] [Abstract][Full Text] [Related]
15. Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects. I: Asthma. Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS Drugs; 1975; 10(3):166-210. PubMed ID: 172309 [TBL] [Abstract][Full Text] [Related]
16. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group. Piquet J; Zuck P; Dennewald G; Dugue P; Grivaux M; Brun P; Severac JC; Ostinelli J; Cheeseman KH Adv Ther; 1996; 13(1):38-50. PubMed ID: 10172710 [TBL] [Abstract][Full Text] [Related]
17. Adrenal function in asthmatics treated with high-dose budesonide. Stiksa G; Nemcek K; Glennow C Respiration; 1985; 48(1):91-3. PubMed ID: 4023443 [TBL] [Abstract][Full Text] [Related]
18. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Clark DJ; Lipworth BJ Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246 [TBL] [Abstract][Full Text] [Related]
19. Inhaled budesonide aerosols in treatment of childhood asthma. Phanichyakarn P; Wong EC Asian Pac J Allergy Immunol; 1988 Dec; 6(2):111-5. PubMed ID: 3219157 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic advantages of twice-daily over four-times daily inhalation budesonide in the treatment of chronic asthma. Nyholm E; Frame MH; Cayton RM Eur J Respir Dis; 1984 Jul; 65(5):339-45. PubMed ID: 6745335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]